Glaukos (GKOS) Cash from Operations Growth (1y) (2015 - 2026)
Glaukos (GKOS) Cash from Operations Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -12.60% |
| 10 | Glaukos | 10.83 Bn | 10.71 Bn | 151.59 Mn | 112.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.39% |
| Mar 31, 2026 | 32.37% |
| Dec 31, 2025 | 1,247.53% |
| Sep 30, 2025 | -5.26% |
| Jun 30, 2025 | 137.99% |
| Mar 31, 2025 | 45.32% |
| Dec 31, 2024 | 104.75% |
| Sep 30, 2024 | -17.36% |
| Jun 30, 2024 | -125.08% |
| Mar 31, 2024 | -10.10% |
| Dec 31, 2023 | -157.86% |
| Sep 30, 2023 | 69.19% |
| Jun 30, 2023 | 33.14% |
| Mar 31, 2023 | -414.75% |
| Dec 31, 2022 | 11.07% |
| Sep 30, 2022 | -249.04% |
| Jun 30, 2022 | -265.15% |
| Mar 31, 2022 | 133.94% |
| Dec 31, 2021 | -143.86% |
| Sep 30, 2021 | 285.89% |